GNF-15752-84478 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-12
Dose 1 — Moderna
2021-03-12
Dose 2 — Moderna
2021-12-09
Dose 3 — Moderna
2022-01-14
Registered in v-safe
2022-01-14
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-12-09
Survey response — 12 months, dose 3
MedDRA: Ageusia, Anosmia, Cough, Nasal congestion, Pain, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Fever, body aches, headache, nasal congestion, cough, loss of taste and smell

MedDRA releases: 2024-11 · check-in free text available
2022-12-09
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-12-12
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-12	Moderna	No
2	2021-03-12	Moderna	No
3	2021-12-09	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 — 12 months, dose 3

2022-12-09

Symptoms: Fever, body aches, headache, nasal congestion, cough, loss of taste and smell

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	·	·	✓
SD	Anosmia	·	·	✓
SD	Cough	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release